The authors are moving toward further development to advance this world class (nasal spray) vaccine technology.
https://www.biorxiv.org/content/10.1101/2022.04.28.489809v1
The next logical step, will be ‘challenge’ in non-human Primates?
Approximately 100 million Americans have contracted Coronavirus (components) either through vaccination or natural infection.
LONG-COVID: One-in-three have complained that they are ‘just not right’ … so you may be able to think of this (nasal spray) T4 Phage construction as a “Therapeutic”, as well as prevention.
Reminder, that reports regarding the Pfizer “Paxlovid” antiviral pill, seems to allow regeneration/less kill rate of the resident CoV (soon after completing the course of 10 pills), which is very disappointing. Only 20 million courses were purchased. It takes 8 months to make a pill, according to reporting.
Generally people do not like needles (better compliance is needed); delivery in the US Mail; stable at room temperature; team is working on cGMP; may prove less shedding; may prove fewer re-infections; deserves T Cells distribution in various important tissues analysis; rapid turnaround times, as virulent types are discovered; moduler & flexibility, built in.
Random CoV variant waves are presenting every 4 to 6 months. We see no end to this reality.
Also, Government wants a UNIVERSAL FLU VACCINE …. https://grants.nih.gov/grants/guide/notice-files/NOT-AI-22-013.html
The same vaccine platform can serve as prevention vs many different diseases; simply exchange the antigens/epitopes.
Clark Tibbs, CEO
PhageVax, Inc.
Cell: 740.502.9010